Provided by Tiger Trade Technology Pte. Ltd.

Virax Biolabs Group Limited

0.2775
-0.0285-9.31%
Post-market: 0.28600.0085+3.06%19:59 EDT
Volume:11.87M
Turnover:3.76M
Market Cap:5.53M
PE:-0.22
High:0.3421
Open:0.3216
Low:0.2711
Close:0.3060
52wk High:1.14
52wk Low:0.1000
Shares:19.92M
Float Shares:6.99M
Volume Ratio:0.06
T/O Rate:169.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2376
EPS(LYR):-1.6248
ROE:-83.82%
ROA:-48.40%
PB:1.04
PE(LYR):-0.17

Loading ...

Virax Biolabs announces extraordinary shareholder meeting

Reuters
·
Yesterday

Why Is Virax Biolabs (VRAX) Stock Trending Overnight?

Benzinga
·
May 19

Virax Biolabs CEO outlines strategic priorities, near-term milestones

TIPRANKS
·
Apr 14

Virax Biolabs announces availability of shareholder letter from CEO James Foster

Reuters
·
Apr 14

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

THOMSON REUTERS
·
Apr 14

Virax Biolabs raises $5 million in private placement via pre-funded warrants, options

Reuters
·
Apr 11

Virax Biolabs director Nelson Haight files initial beneficial ownership statement

Reuters
·
Apr 01

Virax Biolabs Group Ltd. COO and Director Nigel William McCracken files initial beneficial ownership statement

Reuters
·
Mar 20

Virax Biolabs Delays 2025 Annual Shareholder Meeting After Failing to Reach Quorum, Reschedules for March 18, 2026

Reuters
·
Mar 19

Virax Biolabs Group names director Evan Michael Norton in initial beneficial ownership filing

Reuters
·
Mar 19

Virax Biolabs Director Iain David Miller Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

TIPRANKS
·
Jan 10

Virax Biolabs Raises $5 Million in Private Placement Sale of Shares

Reuters
·
Dec 05, 2025

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

THOMSON REUTERS
·
Dec 05, 2025

Press Release: Virax Biolabs Group Limited Announces $5 Million Private Placement

Dow Jones
·
Dec 04, 2025

Crude Oil Gains 1%; Macy's Reports Strong Q3 Results

Benzinga
·
Dec 04, 2025

Virax Biolabs Highlights Clinical Progress and Outlines 2026 Strategic Priorities

Reuters
·
Dec 03, 2025